What Is Tessalin?
Tessalin is a synthetic neuropeptide belonging to a class of compounds designed to cross the blood-brain barrier and exert direct effects on neuronal populations involved in cognition, memory consolidation, and neuroprotection. Its development follows a lineage of nootropic peptide research that includes compounds such as Semax, Selank, and Dihexa.
Tessalin is characterized by its affinity for neurotrophic signaling pathways — particularly those associated with Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF). These neurotrophins play critical roles in the survival, growth, and maintenance of neurons, and their decline has been associated with age-related cognitive impairment and neurodegenerative conditions.
Mechanism of Action
Tessalin's proposed mechanisms center on neurotrophic and neuroprotective signaling:
- BDNF pathway activation: Tessalin is believed to promote the expression and release of Brain-Derived Neurotrophic Factor (BDNF), a key protein supporting the survival and growth of existing neurons and encouraging new synapse formation. BDNF is widely studied in the context of learning, memory, and depression.
- NGF modulation: Nerve Growth Factor (NGF) is critical for the maintenance of cholinergic neurons in the basal forebrain — neurons strongly implicated in memory and attention. Tessalin's interaction with NGF signaling represents one of its primary mechanistic pathways of interest.
- Glutamatergic system support: Preclinical data suggests Tessalin may modulate NMDA receptor sensitivity, which plays a central role in long-term potentiation (LTP) — the cellular mechanism underlying memory formation.
- Oxidative stress reduction in neural tissue: Tessalin appears to upregulate antioxidant defenses in neuronal populations, reducing oxidative damage that accumulates with age.
- Neuroinflammation modulation: By suppressing microglial overactivation and reducing pro-inflammatory signaling in the CNS, Tessalin may help maintain a neuronal environment conducive to optimal function.
Reported Research Benefits
Cognitive Enhancement
Preclinical models suggest Tessalin may improve working memory, spatial learning, and information processing speed. These effects appear to be mediated through neurotrophic actions and modulation of cholinergic signaling.
Neuroprotection
One of the most significant areas of interest for Tessalin is its potential protective effect on neurons under conditions of stress, hypoxia, or excitotoxicity. Animal models examining similar neuropeptides have shown meaningful reductions in neuronal cell death following ischemic injury.
Mood and Anxiety Regulation
BDNF deficiency has been closely linked to both depression and anxiety in preclinical models and human studies. Compounds that upregulate BDNF have correspondingly shown antidepressant and anxiolytic effects. Tessalin's proposed BDNF-modulating activity places it in this area of active research interest.
Neuroplasticity Support
Neuroplasticity — the brain's capacity to reorganize synaptic connections — is foundational to learning and adaptation. Research on neurotrophic peptides suggests compounds like Tessalin may enhance synaptic plasticity, making it of particular interest to researchers studying cognitive aging and rehabilitation.
Reconstitution Protocol
Tessalin is supplied as a lyophilized powder requiring reconstitution with Bacteriostatic Water (BAC water) for subcutaneous injection. For intranasal administration, some researchers use sterile saline to minimize irritation.
- Wipe rubber stoppers of both vials with alcohol swabs. Allow to air dry completely.
- Draw the required BAC water volume into a clean insulin syringe.
- Insert the needle at an angle and slowly deposit BAC water along the inner vial wall — never directly onto the lyophilized cake.
- Gently swirl until completely dissolved. Solution should be clear and colorless.
- Label the vial with the peptide name, concentration, and date. Refrigerate immediately.
Reconstitution Reference Table
| Vial Size | BAC Water Added | Concentration | 100 mcg Dose | 200 mcg Dose |
|---|---|---|---|---|
| 5 mg | 2.5 mL | 2,000 mcg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) |
| 5 mg | 5 mL | 1,000 mcg/mL | 0.10 mL (10 units) | 0.20 mL (20 units) |
| 10 mg | 5 mL | 2,000 mcg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) |
Dosage Protocol
| Category | Dose | Frequency | Notes |
|---|---|---|---|
| Conservative / Entry | 100 mcg | Once daily | Recommended starting dose; assess over 1–2 weeks |
| Standard Research | 200–300 mcg | Once daily | Primary research dosing window |
| Higher Dose | 300–500 mcg | Once daily | Limited additional data; proceed with caution |
Side Effects & Safety Considerations
Given Tessalin's early-stage research status, comprehensive human safety data is not available. The following reflects what can be inferred from related neuropeptide research.
- Neuropeptides as a class have generally favorable safety profiles in animal models at studied doses
- Injection site reactions (mild redness, bruising) are common with any SQ injection
- Headache and mild fatigue have been reported anecdotally with various neuropeptides, particularly early in a cycle
- Changes in sleep architecture have been noted with BDNF-modulating compounds in some individuals
- Individuals with seizure disorders or psychiatric conditions should exercise particular caution
- Interactions with prescribed psychiatric medications have not been characterized
Storage Guidelines
| State | Temperature | Duration | Notes |
|---|---|---|---|
| Lyophilized powder | Refrigerator (2–8°C) | Up to 18–24 months | Protect from light and moisture |
| Reconstituted solution | Refrigerator (2–8°C) | Up to 21 days | Discard if cloudy or discolored |
| Long-term lyophilized | Freezer (−20°C) | Up to 36 months | Do not freeze reconstituted solution |
Ready to Source Tessalin?
Purchase Tessalin vials and a complete starter kit from our trusted research supplier. Everything you need to begin your protocol.
Research Context & Sources
- Huang, E.J. & Reichardt, L.F. (2001). "Neurotrophins: Roles in Neuronal Development and Function." Annual Review of Neuroscience.
- Gudasheva, T.A. et al. (2015). "Dipeptide mimetics of nerve growth factor." Acta Naturae.
- Dolotov, O.V. et al. (2006). "Semax protects against ischemic brain injury and reduces cortical neuronal death." Journal of Neurochemistry.
- Kolomin, T. et al. (2013). "BDNF related peptide treatment effects on hippocampal neurogenesis." BMC Neuroscience.